Newer treatment in dermatology.
The future of a drug depends upon what it can do in the hands of the practitioner. Medicine is practiced on the basis of probabilities, and treatment must be selected which has the best chance of helping the patient, with the least amount of harm. There are many new drugs available for dermatologic therapy in other developed countries which are not available in this country, due to peculiarities of federal drug regulations.
D000152:Acne Vulgaris / Q000188:drug therapy; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002338:Carotenoids / Q000627:therapeutic use; D003879:Dermatologic Agents / Q000627:therapeutic use*; D005472:Fluorouracil / Q000627:therapeutic use; D006566:Herpesviridae Infections / Q000188:drug therapy; D006801:Humans; D007641:Keratolytic Agents / Q000627:therapeutic use; D010787:Photosensitivity Disorders / Q000188:drug therapy; D011565:Psoriasis / Q000188:drug therapy; D012871:Skin Diseases / Q000188:drug therapy*; D014212:Tretinoin / Q000627:therapeutic use; D014481:United States; D014486:United States Food and Drug Administration; D014810:Vitamin E / Q000627:therapeutic use; D014820:Vitiligo / Q000188:drug therapy
D000305:Adrenal Cortex Hormones; D000935:Antifungal Agents; D000970:Antineoplastic Agents; D003879:Dermatologic Agents; D007641:Keratolytic Agents; D014810:Vitamin E; D002338:Carotenoids; D014212:Tretinoin; D005472:Fluorouracil